Fig. 2From: Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot studyMonocyte HLA-DR kinetics. Monocyte HLA-DR antibody per cell surface expression from admission to day 8–10 in patients with secondary infection (a) or survivors at day 28 (b). *p < 0.05Back to article page